NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

This Week on NeurologyLive® — July 17, 2023

This Week on NeurologyLive® — July 17, 2023

NeurologyLive® Staff
July 17th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Polyunsaturated Fats and ALS Disease Progression, CAP-1002 Improves Motor Function in DMD, Lecanemab Granted Traditional Approval

Polyunsaturated Fats and ALS Disease Progression, CAP-1002 Improves Motor Function in DMD, Lecanemab Granted Traditional Approval

NeurologyLive® Staff
July 15th 2023

Neurology News Network for the week ending July 15, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — July 14, 2023

NeurologyLive® Friday 5 — July 14, 2023

NeurologyLive® Staff
July 14th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 14, 2023.

This Week on NeurologyLive® — July 10, 2023

This Week on NeurologyLive® — July 10, 2023

NeurologyLive® Staff
July 10th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function

Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function

NeurologyLive® Staff
July 8th 2023

Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — July 7, 2023

NeurologyLive® Friday 5 — July 7, 2023

NeurologyLive® Staff
July 7th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 7, 2023.

This Week on NeurologyLive® — July 3, 2023

This Week on NeurologyLive® — July 3, 2023

NeurologyLive® Staff
July 3rd 2023

Here's some of what is coming soon to NeurologyLive® this week.

Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays

Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays

NeurologyLive® Staff
July 1st 2023

Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — June 30, 2023

NeurologyLive® Friday 5 — June 30, 2023

NeurologyLive® Staff
June 30th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 30, 2023.

This Week on NeurologyLive® — June 26, 2023

This Week on NeurologyLive® — June 26, 2023

NeurologyLive® Staff
June 26th 2023

Here's some of what is coming soon to NeurologyLive® this week.

CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine

CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine

NeurologyLive® Staff
June 24th 2023

Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — June 23, 2023

NeurologyLive® Friday 5 — June 23, 2023

NeurologyLive® Staff
June 23rd 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 23, 2023.

This Week on NeurologyLive® — June 19, 2023

This Week on NeurologyLive® — June 19, 2023

NeurologyLive® Staff
June 19th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review

Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review

NeurologyLive® Staff
June 17th 2023

Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]

This Week on NeurologyLive® — June 12, 2023

This Week on NeurologyLive® — June 12, 2023

NeurologyLive® Staff
June 12th 2023

Here's some of what is coming soon to NeurologyLive® this week.

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

NeurologyLive® Staff
June 10th 2023

Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — June 9, 2023

NeurologyLive® Friday 5 — June 9, 2023

NeurologyLive® Staff
June 9th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 9, 2023.

This Week on NeurologyLive® — June 5, 2023

This Week on NeurologyLive® — June 5, 2023

NeurologyLive® Staff
June 5th 2023

Here's some of what is coming soon to NeurologyLive® this week.

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

NeurologyLive® Staff
June 3rd 2023

Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — June 2, 2023

NeurologyLive® Friday 5 — June 2, 2023

NeurologyLive® Staff
June 2nd 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 2, 2023.

This Week on NeurologyLive® — May 29, 2023

This Week on NeurologyLive® — May 29, 2023

NeurologyLive® Staff
May 29th 2023

Here's some of what is coming soon to NeurologyLive® this week.

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

NeurologyLive® Staff
May 27th 2023

Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — May 26, 2023

NeurologyLive® Friday 5 — May 26, 2023

NeurologyLive® Staff
May 26th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 26, 2023.

This Week on NeurologyLive® — May 22, 2023

This Week on NeurologyLive® — May 22, 2023

NeurologyLive® Staff
May 22nd 2023

Here's some of what is coming soon to NeurologyLive® this week.

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

NeurologyLive® Staff
May 20th 2023

Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 19, 2023

NeurologyLive® Friday 5 — May 19, 2023

NeurologyLive® Staff
May 19th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 19, 2023.

This Week on NeurologyLive® — May 15, 2023

This Week on NeurologyLive® — May 15, 2023

NeurologyLive® Staff
May 15th 2023

Here's some of what is coming soon to NeurologyLive® this week.

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

NeurologyLive® Staff
May 13th 2023

Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — May 12, 2023

NeurologyLive® Friday 5 — May 12, 2023

NeurologyLive® Staff
May 12th 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 12, 2023.

This Week on NeurologyLive® — May 8, 2023

This Week on NeurologyLive® — May 8, 2023

NeurologyLive® Staff
May 8th 2023

Here's some of what is coming soon to NeurologyLive® this week.

<1
...
91011121314151617
...
37>

Latest Updated Articles

Anna Burke, MD (Credit: Barrow Neurological Institute)
Published: July 28th 2025 | Updated: July 30th 2025
Indirect Comparison Study Hints at Lower ARIA and ICH-Related Mortality Risk in Lecanemab Over Donanemab
Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
© 2025 MJH Life Sciences

All rights reserved.